{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:12:38Z","timestamp":1793103158580,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"European Society for Clinical Microbiology and Infectious DiseasesEuropean Society for Clinical Microbiology and Infectious Diseases (ESCMID)","id":[{"id":"https:\/\/ror.org\/02vkssr45","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cmi.2017.08.025","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T13:15:13Z","timestamp":1504617313000},"page":"118-124","source":"Crossref","is-referenced-by-count":154,"title":["To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis"],"prefix":"10.1016","volume":"24","author":[{"given":"R.B.","family":"Dessau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fingerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-P.","family":"Hunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jaulhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kristoferitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-E.","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Markowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.08.025_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.08.025_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cmi.2017.08.025_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/595427","article-title":"Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis","volume":"2012","author":"Muller","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.cmi.2017.08.025_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-10-317","article-title":"Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: survey of patients seen in general practice","volume":"10","author":"Dessau","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10096-014-2129-4","article-title":"Borrelia burgdorferi sensu lato serology in The Netherlands: guidelines versus daily practice","volume":"33","author":"Coumou","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib6","series-title":"Rijksinstituut voor Volksgezonheid en Milieu","year":"2013"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.cmi.2017.08.025_bib7","first-page":"S153","article-title":"Lyme borreliose: diagnostic, therapeutic and preventive approaches","volume":"37","author":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise","year":"2007","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2017.08.025_bib8","series-title":"Lyme borreliose: klinik, diagnostik og behandling (Danish guideline)","first-page":"50","author":"Dessau","year":"2014"},{"key":"10.1016\/j.cmi.2017.08.025_bib9","series-title":"Borrelia. Molecular biology, host interaction and pathogenesis","first-page":"299","article-title":"Pathobiology of Lyme disease borrelia","author":"Norris","year":"2010"},{"key":"10.1016\/j.cmi.2017.08.025_bib10","series-title":"Borrelia. Molecular biology, host interaction and pathogenesis","first-page":"487","article-title":"Lyme disease in humans","author":"Radolf","year":"2010"},{"key":"10.1016\/j.cmi.2017.08.025_bib11","series-title":"Borrelia. Molecular biology, host interaction and pathogenesis","first-page":"443","article-title":"Detection of Borrelia burgdorferi","author":"Wang","year":"2010"},{"key":"10.1016\/j.cmi.2017.08.025_bib12","article-title":"Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR","volume":"8","author":"O'Rourke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.08.025_bib13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/JCM.40.4.1249-1253.2002","article-title":"Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings","volume":"40","author":"Liveris","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/17530059.2011.555396","article-title":"Molecular diagnosis of Borrelia bacteria for the diagnosis of Lyme disease","volume":"5","author":"van Dam","year":"2011","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.cmi.2017.08.025_bib15","series-title":"Molecular biology, host interaction and pathogenesis","author":"Borrelia","year":"2010"},{"key":"10.1016\/j.cmi.2017.08.025_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12879-016-1468-4","article-title":"The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis","volume":"16","author":"Leeflang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168613","article-title":"The accuracy of diagnostic tests for Lyme disease in humans, a systematic review and meta-analysis of North American Research","volume":"11","author":"Waddell","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.08.025_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00579624","article-title":"Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay","volume":"182","author":"Wilske","year":"1993","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"10.1016\/j.cmi.2017.08.025_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1574-695X.2006.00139.x","article-title":"Microbiological and serological diagnosis of Lyme borreliosis","volume":"49","author":"Wilske","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/JCM.26.2.338-346.1988","article-title":"Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease","volume":"26","author":"Hansen","year":"1988","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JCM.27.3.545-551.1989","article-title":"Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay","volume":"27","author":"Hansen","year":"1989","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.410300212","article-title":"Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi\u2014specific immunoglobulin G, A, and M","volume":"30","author":"Hansen","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cmi.2017.08.025_bib23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib24","first-page":"1","article-title":"Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985\u20131990","volume":"151","author":"Hansen","year":"1994","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.cmi.2017.08.025_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3201\/eid2101.140009","article-title":"Antibodies against Borrelia burgdorferi sensu lato among adults, Germany, 2008\u20132011","volume":"21","author":"Wilking","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib26","first-page":"257","article-title":"Seroepidemiological study of Lyme borreliosis among forestry workers in southern Poland","volume":"16","author":"Buczek","year":"2009","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.cmi.2017.08.025_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00508-006-0694-y","article-title":"Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters","volume":"118","author":"Cetin","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.cmi.2017.08.025_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijmm.2008.06.001","article-title":"Tick bites in a Lyme borreliosis highly endemic area in Switzerland","volume":"299","author":"Hugli","year":"2009","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.jid.5700160","article-title":"Epidemiology of tick bites and borreliosis in children attending kindergarten or so-called \u201cforest kindergarten\u201d in Southwest Germany","volume":"126","author":"Weisshaar","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cmi.2017.08.025_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00365549850161520","article-title":"IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland","volume":"30","author":"Carlsson","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10096-007-0342-0","article-title":"Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome","volume":"26","author":"Seidel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmi.2014.11.014","article-title":"Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in The Netherlands","volume":"21","author":"Coumou","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.08.025_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007627","article-title":"Seronegative lyme neuroborreliosis in a patient using rituximab","author":"van Dop","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cmi.2017.08.025_bib34","article-title":"Lyme carditis in an immunocompromised patient","volume":"2013","author":"Ryan","year":"2013","journal-title":"Case Rep Emerg Med"},{"key":"10.1016\/j.cmi.2017.08.025_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s15010-007-6121-0","article-title":"Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia","volume":"35","author":"Harrer","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.08.025_bib36","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.45.9.1663","article-title":"Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis","volume":"45","author":"Tumani","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2017.08.025_bib37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/01.wnl.0000269672.17807.e0","article-title":"Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients","volume":"69","author":"Blanc","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2017.08.025_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","article-title":"Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis","volume":"14","author":"Ljostad","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cmi.2017.08.025_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/115.2.399","article-title":"The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985\u20131990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production","volume":"115","author":"Hansen","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.cmi.2017.08.025_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.142.7.862","article-title":"Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients","volume":"142","author":"Glatz","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cmi.2017.08.025_bib43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","article-title":"High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice","volume":"18","author":"Seriburi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.08.025_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02561539","article-title":"Epstein\u2013Barr virus and cytomegalovirus infections cause false-positive results in IgM two-test protocol for early Lyme borreliosis","volume":"27","author":"Goossens","year":"1999","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.08.025_bib45","series-title":"European multicenter study for evaluation of a new enzyme immunoassayfor detection of IgG antibodies against Borrelia burgdorferi sensu lato","author":"Hunfeld","year":"2005"},{"key":"10.1016\/j.cmi.2017.08.025_bib46","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1099\/jmm.0.061275-0","article-title":"Diagnostic accuracy and comparison of two assays for Borrelia-specific IgG and IgM antibodies: proposals for statistical evaluation methods, cut-off values and standardization","volume":"62","author":"Dessau","year":"2013","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0463.2010.02594.x","article-title":"Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis: graphical and bivariate analyses","volume":"118","author":"Dessau","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.cmi.2017.08.025_bib48","series-title":"Combining multiple test results. The statistical evaluation of medical tests for classification and prediction","first-page":"267","author":"Pepe","year":"2003"},{"key":"10.1016\/j.cmi.2017.08.025_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000213074","article-title":"When is the best time to order a Western blot and how should it be interpreted?","volume":"37","author":"Hunfeld","year":"2009","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.cmi.2017.08.025_bib50","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/JCM.43.8.3602-3609.2005","article-title":"Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues","volume":"43","author":"Goettner","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib51","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/JCM.37.7.2241-2247.1999","article-title":"Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe","volume":"37","author":"Hauser","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib52","series-title":"Clinical laboratory diagnostics","article-title":"Borreliosis","author":"Hunfeld","year":"2017"},{"key":"10.1016\/j.cmi.2017.08.025_bib53","first-page":"590","article-title":"Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease","volume":"44","author":"CDC","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2017.08.025_bib54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2017.08.025_bib55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1469-0691.2004.01019.x","article-title":"Guidelines for the diagnosis of tick-borne bacterial diseases in Europe","volume":"10","author":"Brouqui","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.08.025_bib56","series-title":"Qualit\u00e4tsstandards in der mikrobiologisch-infektiologischen Diagnostik.Munich","first-page":"1","article-title":"MIQ12, Lyme-borreliose","author":"Wilske","year":"2000"},{"key":"10.1016\/j.cmi.2017.08.025_bib57","series-title":"Report from a survey of laboratory methods used in Scandinavia. Testing for Lyme borreliosis in the Nordic countries\u2014variations in strategies and rate of seropositivity","author":"Dessau","year":"2011"},{"key":"10.1016\/j.cmi.2017.08.025_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00430-013-0315-0","article-title":"Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa","volume":"203","author":"Wormser","year":"2014","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.cmi.2017.08.025_bib59","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/JCM.38.6.2097-2102.2000","article-title":"A\u00a0European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis","volume":"38","author":"Robertson","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1099\/jmm.0.000009","article-title":"Multiplex assay (Mikrogen recomBead) for detection of serum IgG and IgM antibodies to 13 recombinant antigens of Borrelia burgdorferi sensu lato in patients with neuroborreliosis. The more the better?","volume":"64","author":"Dessau","year":"2015","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10096-011-1157-6","article-title":"Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots","volume":"30","author":"Ang","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib62","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JCM.35.6.1433-1444.1997","article-title":"Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato","volume":"35","author":"Hauser","year":"1997","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.08.025_bib63","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/374376","article-title":"Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease","volume":"187","author":"Peltomaa","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib64","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10096-004-1163-z","article-title":"Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis","volume":"23","author":"Fleming","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/CVI.00026-15","article-title":"Changes in antibody reactivity to Borrelia burgdorferi three months after a tick bite. A cohort of 1,886 persons","volume":"22","author":"Dessau","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2017.08.025_bib66","series-title":"Statistical methods in diagnostic medicine","first-page":"13","article-title":"Measures of diagnostic accuracy","author":"Zhou","year":"2011"},{"key":"10.1016\/j.cmi.2017.08.025_bib67","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.28.21184","article-title":"Improving national surveillance of Lyme neuroborreliosis in Denmark through electronic reporting of specific antibody index testing from 2010 to 2012","volume":"20","author":"Dessau","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2017.08.025_bib68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0025-7125(03)00089-0","article-title":"Laboratory testing for suspected Lyme disease","volume":"86","author":"Bunikis","year":"2002","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cmi.2017.08.025_bib69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","article-title":"CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine","volume":"85","author":"Rupprecht","year":"2014","journal-title":"Nervenarzt"},{"key":"10.1016\/j.cmi.2017.08.025_bib70","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/CDLI.12.8.910-917.2005","article-title":"Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis","volume":"12","author":"Rauter","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cmi.2017.08.025_bib71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.idc.2007.12.005","article-title":"Lyme disease: laboratory issues","volume":"22","author":"Aguero-Rosenfeld","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cmi.2017.08.025_bib72","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.diagmicrobio.2008.08.016","article-title":"Percent positive rate of Lyme real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and tissue","volume":"62","author":"Babady","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib73","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.30384","article-title":"Burden and viability of Borrelia burgdorferi in skin or joints, of patients with erythema migrans or lyme arthritis","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cmi.2017.08.025_bib74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis","volume":"81","author":"Senel","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cmi.2017.08.025_bib75","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A\u00a0prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2017.08.025_bib76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.cmi.2017.08.025_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","article-title":"CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis","volume":"37","author":"Marra","year":"2010","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib78","series-title":"Neuroborreliosis. Guideline of the German Neurological Society","author":"Rauer","year":"2015"},{"key":"10.1016\/j.cmi.2017.08.025_bib79","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4045\/tidsskr.13.1053","article-title":"Cellular Borrelia tests","volume":"134","author":"Tveten","year":"2014","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.cmi.2017.08.025_bib80","doi-asserted-by":"crossref","first-page":"O786","DOI":"10.1111\/1469-0691.12583","article-title":"The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful","volume":"20","author":"Dessau","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.08.025_bib81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/cells1020153","article-title":"Can ELISPOT be applied to a clinical setting as a diagnostic utility for neuroborreliosis?","volume":"1","author":"Nordberg","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.cmi.2017.08.025_bib82","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/23744235.2016.1144932","article-title":"Microscopy of human blood for Borrelia burgdorferi and Babesia without clinical or scientific rationale","volume":"48","author":"Dessau","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2017.08.025_bib83","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/23744235.2016.1144931","article-title":"Validate or falsify: lessons learned from a microscopy method claimed to be useful for detecting Borrelia and Babesia organisms in human blood","volume":"48","author":"Aase","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.cmi.2017.08.025_bib84","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/CVI.00167-09","article-title":"Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls","volume":"16","author":"Marques","year":"2009","journal-title":"Clin Vaccine Immunol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17304883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17304883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T02:25:54Z","timestamp":1659407154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17304883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1198743X17304883"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.08.025","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}